Approved Ligands

D,L-Venlafaxine is an isomer of Venlafaxine . Venlafaxine is a derivative of phenylethylamine which is reported to facilitate neurotransmission within the central nervous system via blocking the presynaptic reuptake of neuroamines such as serotonin

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.A potent and selective inhibitor of Raf-B protein kinase carrying

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.A potent and selective inhibitor of Raf-B protein kinase carrying

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.A potent and selective inhibitor of Raf-B protein kinase carrying

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.A potent and selective inhibitor of Raf-B protein kinase carrying

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.A potent and selective inhibitor of Raf-B protein kinase carrying

Dapagliflozin is a potent and selective SLC5A2 inhibitor with EC50 of 1.1 nM. It has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp). Dapagliflozin is not a significant P-gp inhibitor.A SGLT-2 inhibitor.

Dapagliflozin is a potent and selective SLC5A2 inhibitor with EC50 of 1.1 nM. It has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp). Dapagliflozin is not a significant P-gp inhibitor.A SGLT-2 inhibitor.

Dapagliflozin is a potent and selective SLC5A2 inhibitor with EC50 of 1.1 nM. It has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp). Dapagliflozin is not a significant P-gp inhibitor.A SGLT-2 inhibitor.

Dapagliflozin is a potent and selective SLC5A2 inhibitor with EC50 of 1.1 nM. It has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp). Dapagliflozin is not a significant P-gp inhibitor.A SGLT-2 inhibitor.

Dapagliflozin is a potent and selective SLC5A2 inhibitor with EC50 of 1.1 nM. It has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp). Dapagliflozin is not a significant P-gp inhibitor.A SGLT-2 inhibitor.

Dapagliflozin is a potent and selective SLC5A2 inhibitor with EC50 of 1.1 nM. It has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp). Dapagliflozin is not a significant P-gp inhibitor.A SGLT-2 inhibitor.